Joslin Diabetes Center

Running trials

• Not yet recruiting

  Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo

  NCT07683026· Phase 2· Source

• Recruiting

  App-Based Certified Diabetes Education Therapy (AB-CDE)

  NCT07282639· Source

• Recruiting

  Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  NCT07142252· Phase 2· Source

• Recruiting

  Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  NCT07579702· Source

• Recruiting

  Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  NCT07521475· Source

• Recruiting

  INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

  NCT07224321· Phase 2· Source

• Recruiting

  Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics

  NCT07271043· Source

• Recruiting

  Postnatal Exercise to Activate Baby's Brown Fat

  NCT07467694· Source

• Recruiting

  Exercise, Brain Activity, and Weight Maintenance

  NCT06511310· Source

• Recruiting

  A Study of GNTI-122 in Adults Recently Diagnosed With T1D

  NCT06919354· Phase 1· Source

• Recruiting

  Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  NCT06790784· Phase 3· Source

• Recruiting

  HLA Demographics Study in Adults With Type 1 Diabetes

  NCT06860516· Source

• Recruiting

  CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  NCT06783309· Phase 1/2· Source

• Active, not recruiting

  T1D Pregnancy & Me

  NCT06959316· Source

• Recruiting

  Diabetes Body Project 2

  NCT07468188· Source

• Recruiting

  Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  NCT06217302· Phase 3· Source

• Active, not recruiting

  Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults and Adolescents on Top of Insulin Therapy (FABULINUS)

  NCT06111586· Phase 2· Source

• Active, not recruiting

  Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

  NCT05904028· Phase 3· Source

• Active, not recruiting

  Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

  NCT03929601· Phase 2· Source

• Active, not recruiting

  Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

  NCT05743244· Phase 2· Source

• Active, not recruiting

  Evaluation of Tonabersat for DME

  NCT05727891· Phase 2· Source

• Active, not recruiting

  The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System

  NCT05754281· Source

• Active, not recruiting

  Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes

  NCT05399446· Source

• Recruiting

  PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

  NCT06141434· Source

• Enrolling by invitation

  The Diabetes Prevention Program Outcomes Study AD/ADRD Project

  NCT05704309· Source

• Active, not recruiting

  Fenofibrate for Prevention of DR Worsening

  NCT04661358· Phase 3· Source

• Active, not recruiting

  Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

  NCT04595474· Source

• Recruiting

  Kidney Precision Medicine Project

  NCT04334707· Source

• Active, not recruiting

  A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

  NCT03811561· Phase 3· Source

• Active, not recruiting

  Impact of Metabolic Health on Sperm Epigenetic Marks in Humans

  NCT03860558· Source

• Recruiting

  Type 1 Diabetes Extension Study

  NCT02734277· Source

• Active, not recruiting

  Evaluating the Health Outcomes of the Joslin Why WAIT Program

  NCT01937845· Source

• Recruiting

  TrialNet Pathway to Prevention of T1D

  NCT00097292· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes13 recruiting
• Type 2 diabetes5 recruiting
• Obesity3 recruiting
• Chronic kidney disease2 recruiting
• Alzheimer disease1 recruiting
• Diabetic eye disease1 recruiting
• Heart failure1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Simplified Onboarding in Adults With Type 2 Diabetes

  NCT07070830· Source

• Withdrawn

  SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes

  NCT06719531· Source

• Completed

  Innovative Automated Insulin Delivery System for Type 2 Diabetes

  NCT06853990· Source

• Completed

  Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

  NCT06865989· Source

• Completed

  A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

  NCT06362265· Phase 1· Source

• Completed

  A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

  NCT05901831· Phase 3· Source

• Completed

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06221969· Phase 3· Source

• Completed

  A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

  NCT06045221· Phase 3· Source

• Completed

  INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

  NCT05904743· Phase 4· Source

• Completed

  Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

  NCT05714059· Source

• Completed

  Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

  NCT05683392· Source

• Completed

  Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's

  NCT05535478· Source

• Completed

  A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

  NCT05514535· Phase 3· Source

• Completed

  Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

  NCT05413239· Source

• Completed

  Omnipod 5 System Compared to Pump Therapy

  NCT05409131· Source

• Completed

  A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

  NCT04929379· Phase 2· Source

• Completed

  Afrezza® INHALE-1 Study in Pediatrics

  NCT04974528· Phase 3· Source

• Completed

  Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study

  NCT04409795· Phase 2/3· Source

• Completed

  Effects of a Single Bout of Exercise on Transcriptomics and Metabolomics in Adipose Tissue

  NCT04865965· Source

• Terminated

  IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

  NCT04524949· Phase 2· Source

• Completed

  A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

  NCT04279613· Phase 1· Source

• Completed

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· Phase 2· Source

• Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· Phase 3· Source

• Completed

  Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes

  NCT03895996· Phase 1/2· Source

• Completed

  Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

  NCT02328599· Source

• Completed

  Exercise Regulation of Human Adipose Tissue

  NCT03133156· Source

• Completed

  Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans

  NCT01762046· Phase 1· Source

Trial sites

• Joslin Center For Diabetes1 trial
• Joslin Diabetes Center57 trials
• Joslin Diabetes Center - Boston- Site Number : 84000151 trial
• Joslin Diabetes Center, Harvard Medical School1 trial
• Joslin Diabetes Center, Harvard School of Medicine1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Type 1 diabetes47 works · 36 trials
• Diabetic eye disease13 works · 5 trials